GFR Pharmaceuticals IncShs
[Valor: 1924922 / ISIN: US36169W1009]

GFR Pharmaceuticals IncShs - Курс акции - USD - BEB

Торги в реальном времени
0,00 USD 0,00 USD 0,00 %
Время 23:27 Дата 26.08.2016
Максимум 0,00 Открытие 0,00
Минимум 0,00 Пред. закр. 0,00
Макс. 52 нед. 0,00 Объём (Штук) 0
Мин. 52 нед. 0,00 Рыночная капитализация (RUB)
Изменение курса за 52 недели Биржа
Котировка 0,00 USD на бирже BER соответствует котировке 0,00 в RUB по текущему обменному курсу USD/RUB.

Профиль GFR Pharmaceuticals IncShs

Подробнее
GFR Pharmaceuticals, Inc. leases diagnostic imaging medical equipments to hospitals in the People's Republic of China. The company, through New Century, provides consulting services of chemical technology investment, investment and management of technical project, natural extract, development, production and sales of purification chemicals (except food, medicine, danger goods, poisonous production), research, production and sales of chemical facility, agent service (except sales of medicine and medical facility), commercial consulting service and property management. With the cooperative relationship with the hospitals in China, New Century also provides therapy equipment and the overall service to tumor sufferers. The company has four sets of medical facility, including Masep Srrs Gamma Rays Stereotactic Radiation Therapy System for Heads, Gamma Rays Stereotactic Radiation Therapy, System Philips Pet System, and Canadian Cyclotron System. New Century set up a professional medical Web site to offer online consultant and three service centers for body check and medical treatment. Acquisitions In October 2006, the company acquired 100% of Xi'an Hua Long Yu Tian Ke Ji Shi Ye Co., Ltd. (Hua Long). Hua Long acts as the holding company of New Century Scientific Investment, Ltd. (New Century). In December 2006, the company acquired, through Hua Long, 95% of New Century Scientific Investment, Ltd. (New Century). History GFR Pharmaceuticals, Inc. was founded in 2001.

GFR Pharmaceuticals - Ключевые показатели

Рыночная капитализация (RUB)
Акции в свободном обращении (%)
Объём выпуска 42,08
Денежный поток/акцию в национальной валюте
Балансовая стоимость/акцию в национальной валюте
Волатильность за 60 дней
P/B коэффициент

GFR Pharmaceuticals - Основная информация

Тикер
ISIN US36169W1009
Индексы

GFR Pharmaceuticals - О компании

Страна Китай
GFR Pharmaceuticals Цена и объём - 1 Год - BEB
  • 1H
  • ВСЕ ВРЕМЯ

GFR Pharmaceuticals - Другие компании отрасли